Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials. - Wikidata - wikimedia - TriplyDB

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

http://www.wikidata.org/entity/Q34199968

about

Flavaglines alleviate doxorubicin cardiotoxicity: implication of Hsp27 Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy Different dosage schedules for reducing cardiotoxicity in cancer patients receiving anthracycline chemotherapy Doxorubicin cardiomyopathy Cardiotoxicity in childhood cancer survivors: strategies for prevention and management Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity Cardio-oncology: Concepts and practice Integrative Therapies and Cardiovascular Disease in the Breast Cancer Population: A Review, Part 1 The Crossroads of Geriatric Cardiology and Cardio-Oncology Efficacy and Cardiotoxicity of Liposomal Doxorubicin-Based Chemotherapy in Advanced Breast Cancer: A Meta-Analysis of Ten Randomized Controlled Trials Cardiac effects of anticancer therapy in the elderly Serum biomarkers for the detection of cardiac toxicity after chemotherapy and radiation therapy in breast cancer patients Optimal management of breast cancer in the elderly patient: current perspectives Potential Therapeutic Strategies for Hypertension-Exacerbated Cardiotoxicity of Anticancer Drugs Cardiac risk in the treatment of breast cancer: assessment and management.The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs Redox regulation of mitochondrial function Attenuation of doxorubicin-induced cardiotoxicity by mdivi-1: a mitochondrial division/mitophagy inhibitor Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death Treatment of soft tissue sarcoma: a focus on earlier stages.Cancer drug related cardiotoxicity during breast cancer treatment.Targeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.Point-of-Care Technologies for the Advancement of Precision Medicine in Heart, Lung, Blood, and Sleep Disorders.Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.Cancer therapy-induced cardiotoxicity: basic mechanisms and potential cardioprotective therapies.Improving quality of life in female cancer survivors: current status and future questions.Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In Vivo Pixantrone: a novel aza-anthracenedione in the treatment of non-Hodgkin's lymphomas.Transcriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat model Diagnostic Strategies for Early Recognition of Cancer Therapeutics-Related Cardiac Dysfunction.Phase Ib dose-finding trial of lapatinib plus pegylated liposomal doxorubicin in advanced HER2-positive breast cancer.Non-pegylated liposomal Doxorubicin-cyclophosphamide in sequential regimens with taxanes as neoadjuvant chemotherapy in breast cancer patients.Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas Anthracycline rechallenge using pegylated liposomal doxorubicin in patients with metastatic breast cancer: a pooled analysis using individual data from four prospective trials.Cardio-Oncology: Cancer Therapy-related Cardiovascular Complications in a Molecular Targeted Era: New Concepts and Perspectives.Pregnancy in a patient with cancer and heart failure: challenges and complexities.21st Century Cardio-Oncology: Identifying Cardiac Safety Signals in the Era of Personalized Medicine.

P2860

Q21135010-431DF24E-4179-4EEA-8DD8-287C7CF9A3F5 Q24240568-4DADD5FD-EEC5-43AE-B913-AE3067F0CFCC Q24243810-D4BD47F6-0775-4489-8629-8FB3375940E2 Q24606920-E5F27AAB-C542-48BB-8F59-0AB9B688670A Q24628695-19E5482A-EEDD-4F30-B9DC-12BC0872037F Q26744675-E37F48FF-E4A7-4F7D-BCCB-BAAEF7D9FA5B Q26750878-DECC5811-2A96-4053-83CE-CD05DB29B824 Q26771931-71EB2277-266C-48D6-9218-E7EF3B3FBCEC Q26778666-71344935-CCE6-42DF-9074-1A88D21DA6C8 Q26800140-E59291A7-D607-48CA-9028-B434C858C3A5 Q26863244-7D6F5C86-FD74-4EF6-9384-59C01E8FAC50 Q27007849-F816607F-7C12-4BD4-BBBD-E805258DD970 Q27690879-9CA7BB08-9276-4F1A-9469-05137B4F333E Q28070311-295E1BD2-9BFF-43B1-87F0-9C6B9722A821 Q28081385-7407B16B-505B-4946-A2FE-582365641F67 Q28081504-B642C037-8497-46ED-BB78-1AA11ED9CF5C Q28083073-C7FB2AF4-1319-494A-9778-89BA70CBE135 Q28087776-C5842522-3DA8-4FDA-AE84-2A12D3AEF6AB Q28383361-8E7C6C5E-F1A1-4424-9599-A9747BC217E4 Q28534483-6A4AB461-66DE-4D18-8A1B-B46B8C5C2FD2 Q28579471-118C33EB-6EF0-4E7C-92C5-148B587EA140 Q30240235-FEC5F0F8-754E-4701-96C2-98068165F4C3 Q30251498-83C245EB-7A01-4425-8B65-47B2BB621809 Q30279055-8B9B50D1-7745-4CE0-8D54-0495FCDF707D Q30374876-052651F5-3B1F-446B-8A67-BACDDFD1CD96 Q30401812-F515657F-4E7C-4CF6-81CF-13F36310006E Q30426853-8B4162D2-70F9-4789-9DEB-DD64A7147760 Q30458386-8271F588-42A8-4A49-A090-DFEAA6D24129 Q30897591-980A260F-0A1B-447C-8457-A5D7C780992B Q32183971-A6C1404B-1044-47BC-AA96-E1144BEA17BA Q33376932-3FD1A5E9-F7CA-40B9-AFEF-51CA65837AFA Q33404672-C1052610-CCC9-433F-BDE8-138A89BABD9B Q33565936-491ED944-4A4C-4D37-AF31-CC895CB4659A Q33600072-FF1BC50B-2F8A-4652-B713-06F9358A2558 Q33634964-311A1CB9-0AA0-4A6A-A1CC-82A996D142D3 Q33728214-D5C6D99A-D63E-448D-92F3-0E8346A960B3 Q33729389-54163BA3-DA22-4C0D-8AC7-006AACEDAE92 Q33807542-A38AD674-F2EA-4FA4-8B1B-B6BC0ED1EF8E Q33885550-95D06F05-B617-4533-8884-83B9521C78B3 Q33900003-CB020BA0-F2F0-4FF3-81B4-136D033EEF61

P2860

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

http://www.wikidata.org/entity/Q34199968

description

2003 nî lūn-bûn

@nan

2003 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

name

Congestive heart failure in pa ...... tive analysis of three trials.

@ast

Congestive heart failure in pa ...... tive analysis of three trials.

@en

Congestive heart failure in pa ...... tive analysis of three trials.

@nl

type

label

Congestive heart failure in pa ...... tive analysis of three trials.

@ast

Congestive heart failure in pa ...... tive analysis of three trials.

@en

Congestive heart failure in pa ...... tive analysis of three trials.

@nl

prefLabel

Congestive heart failure in pa ...... tive analysis of three trials.

@ast

Congestive heart failure in pa ...... tive analysis of three trials.

@en

Congestive heart failure in pa ...... tive analysis of three trials.

@nl

P1433

Q34199968-2254BAEE-D20C-4DE5-B784-39C7D8230467

P1476

Q34199968-506834F9-6D84-43FC-881D-BBA64E209A5A

P2093

Q34199968-3F8391D0-DE86-402C-86AD-DE8661C2D187

Q34199968-6C9E3E8B-571C-4787-AAAA-7CCA7E0039D2

Q34199968-F081F0D7-3CAC-4CB5-9E6A-98CAC32144C2

P304

Q34199968-5ED8233D-2037-4A1A-A12B-C28C07952E69

P31

Q34199968-9372C237-6F30-439A-91E9-B40701AE91B2

P356

Q34199968-61A9C802-3904-4817-8959-B688335CF558

P407

Q34199968-1A97A038-F398-4E32-BC0B-C62CE3D482C6

P433

Q34199968-E2D1F760-36B8-4A67-91F1-2B3F0B8F0F62

P478

Q34199968-139C33EC-868C-4586-A1DC-212FB98525C7

P577

Q34199968-778E8C7B-54D2-4B26-8DDC-172D39EF1A1F

P5875

Q34199968-B4E4420B-85E6-4B1E-A7B0-DF06A0880842

P698

Q34199968-66BDF85C-57B2-4F6E-AE08-27E0A5750F7C

P921

Q34199968-4D72099B-73DB-4C50-BF05-492B311B8A33

Q34199968-93914CAD-1A30-444A-B26E-7FAA17E24BF9

P356

P1433

P1476

Congestive heart failure in pa ...... tive analysis of three trials.

@en

P2093

Fredrick S Whaley

http://www.w3.org/2001/XMLSchema#string

Michael S Ewer

http://www.w3.org/2001/XMLSchema#string

Sandra M Swain

http://www.w3.org/2001/XMLSchema#string

P304

2869-2879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.11407

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

97

http://www.w3.org/2001/XMLSchema#string

P577

2003-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7144619

http://www.w3.org/2001/XMLSchema#string

P698

12767102

http://www.w3.org/2001/XMLSchema#string

P921